Canada markets closed

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.78+0.05 (+0.39%)
At close: 04:00PM EDT
12.78 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-11-30
2022-11-30
2021-11-30
2020-11-30
Total Revenue
80,887
76,987
38,627
29,750
17,820
Operating Expenses
Research Development
193,337
189,148
184,497
116,434
66,494
Selling General and Administrative
44,880
42,902
37,997
31,202
16,309
Total Operating Expenses
238,217
232,050
222,494
147,636
82,803
Operating Income or Loss
-157,330
-155,063
-183,867
-117,886
-64,983
Income Before Tax
-144,643
-143,948
-180,360
-117,063
-63,777
Income Tax Expense
-
-
0
131
-20,535
Income from Continuing Operations
-144,733
-143,948
-180,360
-117,194
-43,242
Net Income
-144,733
-143,948
-180,360
-117,194
-43,242
Net Income available to common shareholders
-144,733
-143,948
-180,360
-117,194
-43,242
Basic EPS
-2.74
-
-3.71
-2.73
-2.76
Diluted EPS
-2.74
-
-3.71
-2.73
-2.76
Basic Average Shares
54,152
-
48,608
42,895
15,673
Diluted Average Shares
54,152
-
48,608
42,895
15,673